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Introduction {#sec1}
============

*Edwardsiella piscicida* (formerly included in *Edwardsiella tarda*) is a Gram-negative facultative intracellular bacterial pathogen that causes edwardsiellosis, a serious systemic infectious disease that afflicts more than 20 species of freshwater and marine fish ([@bib1], [@bib30], [@bib32], [@bib33]). This organism is also an opportunistic pathogen of humans, where it can cause gastroenteritis or wound infections and occasionally septicemia ([@bib20]). All close relatives of *E. piscicida*, including *E. tarda*, *E. hoshinae*, *E. ictaluri*, and *E. anguillarum,* also infect farmed fish ([@bib30]). As a result, edwardsiellosis causes severe economic losses in the aquaculture industry worldwide ([@bib26]). Moreover, these pathogens are increasingly becoming resistant to multiple antibiotics ([@bib32]), limiting treatment options for the aquaculture industry and highlighting the need for the development of new prevention strategies, including vaccines ([@bib26]).

*E. piscicida* is thought to initiate infection by attaching to the epithelia of its principal host entry sites, the gastrointestinal tract or gills. Subsequently, the organism can survive and proliferate within host cells, particularly phagocytes ([@bib20]), evading innate immune defenses, before causing hemorrhagic septicemia. Like phylogenetically related Enterobacteriaceae bacteria *Salmonella* spp., *E. piscicida* pathogenicity depends on both its type III secretion system (T3SS) and type VI secretion system (T6SS) as well as their distinct sets of effectors in animal models of infection ([@bib8], [@bib22], [@bib31], [@bib37]). Expression of these virulence-associated secretion systems requires a two-component system, EsrA-EsrB, and an AraC family transcriptional regulator EsrC in *Edwardsiella* bacteria ([@bib28], [@bib38]). However, there is little knowledge of the environmental factors that trigger activation of these virulence-associated secretion systems or of non-T3/T6SS *E. piscicida* gene products required for fitness during infection or in aquatic environments.

Transposon-insertion site sequencing (TIS) is a potent high-throughput approach for determining the genetic requirements for bacterial fitness in distinct conditions ([@bib7], [@bib27]). Usually, highly saturated transposon mutant libraries are created so that TIS-based screens can provide high-resolution maps of the fitness contributions of individual loci and domains ([@bib7]). However, less complex libraries, e.g., arrayed libraries containing mutants with a single insertion in a known genomic location, can also be useful, particularly when experimental bottlenecks are limiting ([@bib2], [@bib10]), such as in some animal models of infection. Defined (or arrayed) mutant libraries, which usually contain one or two insertions per gene, have been created for several pathogens and model organisms, e.g., *Pseudomonas aeruginosa* and *Vibrio cholerae* ([@bib6], [@bib19], [@bib21]), and have proved to be of value for screens where bottlenecks constrain the number of mutants that can screened ([@bib10]). Moreover, such defined libraries serve as valuable resources because they often consist of collections of insertion mutants in almost all non-essential loci for an organism of interest.

Here, we created a comprehensive defined transposon mutant library in *E. piscicida* EIB202, a highly pathogenic isolate derived from a moribund turbot (*Scophthalmus maximus*) ([@bib32]). We used pooled subsets of this library to analyze the fitness consequences of \>7,000 insertion mutants during growth in media, in phagocytes and *in vivo*. An additional screen of the insertion mutants that had reduced fitness in turbot led to the identification of EvrA (ETAE\_ 2071, [E]{.ul}dwardsiella [v]{.ul}irulence [r]{.ul}egulator [A]{.ul}), a transcription factor that directly activates expression of *esrB,* thereby leading to increased T3/T6SS expression ([@bib22], [@bib38]). Mannose imported into *E. piscicida* as mannose-6-phosphate (man-6P) binds to EvrA, promoting its activation of *esrB* expression. Moreover, mannose is present in host tissue and elevates *E. piscicida* virulence in fish. Thus, mannose appears to serve as a host-derived cue that activates a genetic circuit facilitating pathogenicity.

Results {#sec2}
=======

Identification of Genes Important for Pathogen Growth in Fish Using a Defined Transposon Insertion Mutant Library {#sec2.1}
-----------------------------------------------------------------------------------------------------------------

To facilitate genome-scale studies of the fish pathogen *E. piscicida* (formerly included in *E. tarda*) ([@bib32], [@bib1], [@bib30]), we created a library of transposon mutants, where the site of each insertion was determined. MKGR, a derivative of the mariner transposon *Himar1* ([@bib29]), was engineered for these studies ([Figure 1](#fig1){ref-type="fig"}A). Mutants generated by MKGR insertion should be resistant to gentamicin (Gm) and exhibit mCherry fluorescence, and a subset of mutants, with insertions downstream of active promoters, will be resistant to Km and exhibit GFP fluorescence; this expectation was confirmed experimentally ([Figures S1](#mmc1){ref-type="supplementary-material"}A and [1](#fig1){ref-type="fig"}B).Figure 1Utilization of a Defined *E. piscicida* Transposon Insertion Mutant Library to Characterize Requirements for Pathogen Growth in Different Environments(A) Schematic of the MKGR transposon and workflow overview for defined mutant library generation and subsequent TIS analysis.(B--D) Scatterplots of input (LB grown) and output abundance of transposon insertion mutants after growth in DMEM (B), J774A.1 macrophages (C), and turbot fish (D). Genes with under-representation in the outputs ("significantly depleted"), based on a cutoff of Log~2~(Output/Input) (fold change, FC) ≤ −2.0 and p \< 0.05, are highlighted in blue triangles; the FC of T3SS (pink squares) and T6SS (cyan diamonds) genes are also shown.(E) Venn diagram depicting conditionally depleted genes from the three conditions tested. There were no depleted genes in common across all conditions.

The MKGR transposon was delivered by conjugation into *E. piscicida* EIB202 (ΔP), an otherwise wild-type (WT) and fully virulent strain cured of the endogenous R plasmid pEIB202 encoding genes resisting to various antibiotics, including chloramphenicol (Cm) ([Figures 1](#fig1){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}A) ([@bib32]). Individual insertion mutants were manually picked into 96-well plates. The insertion sites of mutants were sequenced and mapped to the EIB202 genome ([Figures 1](#fig1){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}B--S2E, [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc2){ref-type="supplementary-material"}). A total of 2,806 of the 3,599 predicted coding genes were disrupted with an average of approximately five insertions per gene ([Table S1](#mmc1){ref-type="supplementary-material"}). The 78.0% ORF coverage (2,806/3,599) in the *E. piscicida* defined mutant library is similar to that reported for defined libraries created in other pathogens ([@bib6], [@bib13], [@bib14]).

To overcome experimental limitations present with very-high-density transposon libraries, e.g., infection bottlenecks ([@bib7], [@bib10]), a subset library composed of 7,299 randomly selected mutants, including one or two distinct insertions for each disrupted protein coding gene and intergenic region, was assembled from the set of 20,346 unique insertion mutants ([Tables S1](#mmc1){ref-type="supplementary-material"}, [S2](#mmc2){ref-type="supplementary-material"}, [S3](#mmc3){ref-type="supplementary-material"}, [S4](#mmc4){ref-type="supplementary-material"}, [S5](#mmc5){ref-type="supplementary-material"}, [S6](#mmc6){ref-type="supplementary-material"}, and [S7](#mmc1){ref-type="supplementary-material"}). We compared the fitness consequences of the insertion mutations present in this library after growth in Dulbecco\'s Modified Eagle\'s medium (DMEM), murine macrophage-like J774A.1 cells, where *E. piscicida* grows intracellularly ([@bib8], [@bib22], [@bib23]), and in turbot, a natural *E. piscicida* host ([Figures 1](#fig1){ref-type="fig"}B--1D) ([@bib32]). The library was grown in LB medium, the source of the "input" for TIS analyses, before inoculation into each condition. Mutant bacteria recovered from DMEM, J774A.1 cells, or turbot livers (the most robustly colonized tissue \[[@bib34]\]), were used as "outputs" for TIS analyses. In each condition, correlation coefficients of three biological replicates were high ([Figure S3](#mmc1){ref-type="supplementary-material"}), suggesting that these experiments were not severely compromised by infection bottlenecks or other factors that might stochastically limit library complexity.

There was no overlap in the genes categorized as conditionally depleted (fold change \[FC\] cutoff = 4, p \< 0.05) after growth in DMEM and J774A.1 cells ([Figure 1](#fig1){ref-type="fig"}E) ([Tables S8](#mmc1){ref-type="supplementary-material"} and [S9](#mmc1){ref-type="supplementary-material"}). Genes encoding the T3SS (e.g., *eseB* and *esaM*) ([@bib22], [@bib38]) and T6SS (e.g., *evpC* and *evpI*) ([@bib37]) were not found to be required for growth in DMEM ([Figure 1](#fig1){ref-type="fig"}B), even though this medium is known to promote the transcription of T3SS genes ([@bib22]), illustrating the difference between the genetic requirements for growth and the transcriptional reprogramming that may occur in different environments. In fact, insertions in several key activators of T3SS gene expression including *esrC*, *esrA,* and *esrB*, displayed slightly enhanced fitness (FC \> 1) in DMEM ([Figure 1](#fig1){ref-type="fig"}B), presumably due to reduced metabolic costs associated with production of the T3SS in these mutants ([Figure S4](#mmc1){ref-type="supplementary-material"}A). In contrast to growth in DMEM, *E. piscicida* growth in J774A.1 cells was dependent on several T3SS genes ([Figures 1](#fig1){ref-type="fig"}C and 1E, [Table S9](#mmc1){ref-type="supplementary-material"}), revealing the importance of the pathogen\'s T3SS for macrophage infection. However, T6SS genes did not contribute to the pathogen\'s fitness within J774.A1 cells ([Figure 1](#fig1){ref-type="fig"}C). This observation was confirmed using turbot-derived macrophages and *E. piscicida* strains containing single deletions of *evpP*, *evpC*, or *evpI*, critical T6SS structural genes ([@bib37]); these deletion mutants grew as robustly inside turbot macrophages as the WT strain ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). Thus, the T6SS, which is important for *E. piscicida* growth in turbot ([@bib34]), may primarily promote extracellular growth of the pathogen *in vivo*.

More genes (258) ([Table S10](#mmc1){ref-type="supplementary-material"}) were categorized as conditionally depleted after growth in turbot than in DMEM or macrophages ([Figure 1](#fig1){ref-type="fig"}E), consistent with the idea that the pathogen must rely on a broader array of genes to confront the diverse and changing challenges present in fish tissues. Nearly all of *E. piscicida*\'s genes associated with T3SS (29 of 34) and T6SS (16 of 16) ([Figure 1](#fig1){ref-type="fig"}D) were conditionally depleted in turbot, confirming the importance of these pathogenesis-linked secretion systems ([@bib31], [@bib34], [@bib37]). A genome-scale comparison highlighted the importance of four gene clusters, encoding LPS (region 1, including *waaG*, *waaQ*, *waaL*, *waaF*, *waaC*, *walW*, *walR*, *wabH*, *wabK* \[ETAE_0073--0082\]), and NADH dehydrogenase (region 3, including *nuoM*, *nuoJ*, *nuoI*, *nuoF, nuoD*, and *nuoA*), in addition to the T3SS (region 2) and the T6SS (region 4), as particularly important for *E. piscicida* growth in turbot ([Figure S4](#mmc1){ref-type="supplementary-material"}B) ([Table S11](#mmc1){ref-type="supplementary-material"}). Region 3 genes were also important for growth in J774A.1 cells, suggesting that the pathogen relies on oxidative phosphorylation for growth inside macrophages as well as in fish. Notably, the largest number (56) of conditionally depleted genes in turbot were of unknown function ([Figure S4](#mmc1){ref-type="supplementary-material"}A); future studies defining the functions of these genes will reveal new aspects of pathogen physiology enabling growth *in vivo*.

Validation of Conditional Depleted Genes {#sec2.2}
----------------------------------------

Specific genes from the above-mentioned four regions of interests were chosen ([Figure S4](#mmc1){ref-type="supplementary-material"}B) (*waaQ*, *walW*, *wabK*, *esrA*, *esrB*, *eseB, esaM*, *nuoM*, *nuoA*, *nuoI*, *evpP*, *evpC*, and *evpI*) for validation using in-frame deletion mutants. In these experiments, *E. piscicida* ΔP (WT(ΔP)) was mixed 1:1 with each of these mutants and inoculated into LB, DMEM, J774A.1 cells, or turbot in competition assays. In LB, none of the mutants exhibited growth defects, whereas in DMEM, the mutants with insertions in LPS synthesis genes (*waaQ*, *walW*, and *wabK*) were significantly outcompeted by the WT ([Figure 2](#fig2){ref-type="fig"}A), mirroring the findings from the screen. Similarly, in the competition experiments in J774A.1 cells and turbot, all insertion mutants that were classified as conditionally depleted in the screens exhibited significant defects in the competition assays ([Figures 2](#fig2){ref-type="fig"}B and 2C). Furthermore, the competitive indices found with the *waaQ*, *esrB*, *eseB*, *nuoM*, *evpP*, and *evpI* deletion mutants were similar in J774A.1 cells and turbot primary macrophages ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Thus, the observations from the competition assays strongly correlate with TIS screens. Moreover, there was also an excellent correlation in the fitness measures calculated from the competition and TIS assays (R^2^ = 0.753, [Figure 2](#fig2){ref-type="fig"}D). This correlation was calculated using data presented in [Figures 2](#fig2){ref-type="fig"}A--2C along with similar data obtained with 16 additional mutants containing in-frame deletions in genes that covered a range of FC values calculated in the TIS screens. The strong correlation over a large range of FC values derived from the TIS and competition experiments with deletion mutants suggests that the genome-scale datasets presented in [Figure 1](#fig1){ref-type="fig"} and [Tables S8--S10](#mmc1){ref-type="supplementary-material"} constitute a robust resource for *E. piscicida* studies.Figure 2Validation of TIS Studies with Competitive Assays in DMEM, Macrophages, and Turbot(A--C) Selected in-frame deletion mutants were competed 1:1 versus WT(Δp) in LB and DMEM (A), J774A.1 (B), and turbot fish (C). Competitive indices are shown, and the data presented are mean ± SD from three to nine replicates. \*p \< 0.05, \*\*\*p \< 0.001 based on ANOVA followed by Bonferroni\'s multiple-comparison post-test to compare the data with the values from the WT/WTΔp competitions.(D) Correlation of FC values derived from competition experiments with deletion mutants and from the TIS screen (panels A--C). Each point represents the FC value and standard error (SE) for one gene in both screens. In total, 28 deletion mutants were tested in DMEM, J774A.1, and turbot. A linear regression analysis was used to determine the correlation.

Identification and Characterization of *evrA*, an *In Vivo* Virulence Regulator {#sec2.3}
-------------------------------------------------------------------------------

To identify mutants with defective activation of *E. piscicida*\'s T3SS, we individually screened the 258 insertion mutants found to have growth defects in turbot ([Table S10](#mmc1){ref-type="supplementary-material"}) along with 34 mutants displaying auto-aggregation defects when grown in DMEM ([Table S12](#mmc1){ref-type="supplementary-material"}) for their capacities to enter into and proliferate within J774A.1 cells. Although fewer insertion mutants (34 versus 67) showed deficiencies in intracellular growth from this screen as compared with the initial TIS analysis in J774A.1 cells ([Tables S9](#mmc1){ref-type="supplementary-material"} and [S12](#mmc1){ref-type="supplementary-material"}), most of the mutants that answered this secondary screen (24/34) contained insertions in T3SS-related genes ([Table S12](#mmc1){ref-type="supplementary-material"}). Several of the other mutants had insertions in genes implicated in metabolic processes. One of these genes, ETAE_3493, encodes a homologue of *glnA* (glutamine synthetase), which is known to modulate production of the *E. piscicida* T3SS and to be required for *E. piscicida* pathogenicity ([@bib16], [@bib34]). We focused our work on another mutant, which contained an insertion in ETAE\_ 2071 (hereafter referred to as EvrA for *[E]{.ul}dwardsiella* [v]{.ul}irulence [r]{.ul}egulator [A]{.ul}) because this gene had not previously been linked to the pathogen\'s expression of its T3SS or virulence. Since EvrA bears similarity to the DeoR family of transcriptional regulators, which modulate sugar and nucleotide metabolism in diverse bacteria ([Figure S6](#mmc1){ref-type="supplementary-material"}) ([@bib12], [@bib18]), we speculated that it could provide insight into the metabolic control of expression of *E. piscicida\'*s T3SS. In the initial TIS turbot screen, the *evrA* insertion mutant had an ∼8-fold reduced abundance (FC = 0.13, p \< 0.001) ([Figure 1](#fig1){ref-type="fig"}D) and the *evrA* deletion mutant exhibited a competitive defect versus WT(ΔP) in turbot and in J774A.1 cells and turbot macrophages ([Figures 2](#fig2){ref-type="fig"} and [S5](#mmc1){ref-type="supplementary-material"}B), but not in LB or DMEM ([Figure 2](#fig2){ref-type="fig"}A). Similarly, assayed on its own, the *evrA* deletion mutant exhibited reduced invasion of and/or proliferation within J774A.1 cells and caused less cytotoxicity as well, and both these defects were complementable ([Figures S5](#mmc1){ref-type="supplementary-material"}C and S5D). Moreover, *evrA* transcript abundance was elevated in turbot relative to DMEM ([Figure 3](#fig3){ref-type="fig"}A). Together, these observations suggested that *evrA* may be an *in vivo*-induced regulator of *E. piscicida* virulence.Figure 3EvrA Regulates *E. piscicida* Virulence(A) *evrA* transcript levels in WT *E. piscicida* grown in DMEM (12 h), HeLa cells (8 h.p.i.), J774A.1 cells (6 h.p.i.), and turbot liver (8 d.p.i.), relative to that in the bacteria grown in LB for 12 h. *gyrB* was used as an internal housekeeping control. *n* = 3, \*, p \< 0.05; \*\*\*, p \< 0.001 as compared with LB (arbitrarily set as 1) and DMEM based on Student\'s t test.(B) Auto-aggregation and extracellular protein (ECP) profiles in the indicated strains.(C) Expression of *eseB* in turbot and associated CFU burdens; the indicated strains harboring P~*eseB*~*-luc* reporter plasmids were inoculated into turbot and luminescence and bacterial burden was measured at 8 d.p.i. \*\*\*, p \< 0.001 based on ANOVA analysis of the relative fluorescence units (RFU) and the bacterial burden (*n* = 3).(D) Comparison of transcriptomes of WT and Δ*evrA*. The log~2~ of the ratio of the abundances of each transcript in Δ*evrA* versus WT (M) was plotted against the average log~2~ of the abundance of that transcript in both strains. T3SS, T6SS, and PTS-related genes are highlighted.(E) qRT-PCR analysis of the transcript levels of indicated T3/T6SS genes in Δ*evrA* and Δ*esrB* strains bearing *evrA* or *esrB* expressing plasmids driven by their native promoters or a constitutive P~*lac*~ promoter for *esrB*, relative to that in WT. *gyrB* was used as a control. *n* = 3, \*p \< 0.05, \*\*\*p \< 0.001 based on Student\'s t test.(F) EMSA of EvrA binding to P~*esrB*~. Purified EvrA was added to 20 ng of P~*esrB*~ or mutant (P~*esrB*~ Mut1 and P~*esrB*~ Mut2) Cy5-labeled probes. B, bound DNA; U, unbound DNA.(G) DNase I footprinting analysis of EvrA binding to a site in the *esrB* promoter (shown in the dashed box). Electropherograms show a DNase I digestion of the P~*esrB*~ probe after incubation with 0 or 200 nM of EvrA. The corresponding nucleotide sequence (198 bp 5′ of the translational start codon) protected by EvrA is indicated below. The mutant P~*esrB*~ motifs used for the EMSA in (C) are shown.

We next investigated if EvrA promotes expression of the pathogen\'s T3SS and T6SS. *E. piscicida* aggregates due to the production of EseB, a T3SS apparatus protein, whose expression is directly activated by EsrB, a critical activator of the pathogen\'s T3SS and T6SS ([@bib15], [@bib22], [@bib35]). The *evrA* deletion mutant did not auto-aggregate ([Figure 3](#fig3){ref-type="fig"}B) and produced reduced amounts of T3SS and T6SS proteins in cell lysates ([Figure S5](#mmc1){ref-type="supplementary-material"}E) and in cell supernatants ([Figures 3](#fig3){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}E) as determined by western blot analysis. Reintroduction of *evrA* into Δ*evrA* fully complemented the auto-aggregation and T3/T6SS production defects ([Figures 3](#fig3){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}E), demonstrating that EvrA augments expression of *E. piscicida*\'s T3/T6SS.

*In vivo* bioluminescence imaging was used to investigate T3SS expression during *E. piscicida* infection of turbot ([@bib35]). A luciferase reporter of P~*eseB*~ expression was introduced into a neutral position on the chromosome of WT, Δ*evrA* and Δ*evrA* complemented strains, and these strains were inoculated intraperitoneally into turbot. By 8 days post infection (d.p.i.), when luciferase activity was detected in the WT and complemented strains, P~*eseB*~-*luc* activity was not detectable in the Δ*evrA* background ([Figure 3](#fig3){ref-type="fig"}C). Moreover, there was ∼10--16x fewer Δ*evrA* than WT or the complemented strain CFU recovered from infected fish at this time point ([Figure 3](#fig3){ref-type="fig"}C). Together, these observations suggest that EvrA contributes to *E. picicida* growth in the host by activation of T3SS and T6SS genes.

EvrA Binds Directly to the *esrB* Promoter to Activate Virulence Gene Expression {#sec2.4}
--------------------------------------------------------------------------------

To further elucidate how EvrA modulates *E. piscicida* growth *in vivo*, we used RNA sequencing (RNA-seq) to define the EvrA regulon by comparing the transcriptomes of the WT and Δ*evrA* strains. Transcripts of 166 genes were significantly decreased (log~2~FC \< −1 and p \< 0.05) and 78 were increased (log~2~FC \> 1 and p \< 0.05) in Δ*evrA* compared with the WT ([Figure 3](#fig3){ref-type="fig"}D and [Table S13](#mmc7){ref-type="supplementary-material"}). Many genes in the T3/T6SS gene clusters had lower transcript levels in the *evrA* mutant, consistent with the idea that their expression is activated by EvrA ([Figure 3](#fig3){ref-type="fig"}D and [Table S13](#mmc7){ref-type="supplementary-material"}). qRT-PCR assays corroborated that transcript levels of established T3SS regulatory genes (*esrA*, *esrB*, and *esrC*), T3SS structural genes (*eseB* and *esaM*), and T6SS gene *evpP* were all reduced in the absence of *evrA* but restored in the complemented strain, Δ*evrA* + pUTt-*evrA* ([Figure 3](#fig3){ref-type="fig"}E). Levels of these six transcripts were even lower in the Δ*esrB* mutant, but their levels were not reduced further in an Δ*evrA*Δ*esrB* mutant, suggesting that *evrA* acts upstream of and in the same pathway as *esrB*. Introduction of *esrB* driven by its native promoter into the double mutant only partially restored transcript levels, whereas introduction of *esrB* driven by the unrelated *lac* promoter fully restored transcript amounts to WT or greater levels ([Figure 3](#fig3){ref-type="fig"}E). Collectively, these findings support the idea that EvrA promotes *esrB* expression.

Electrophoretic mobility shifts assays (EMSAs) using purified EvrA were carried out to begin to test whether EvrA directly regulates *esrB* expression. EvrA bound to a DNA probe that included the upstream region of the *esrB* gene ([Figure 3](#fig3){ref-type="fig"}F). The binding site of EvrA in the *esrB* promoter region was defined with a DNase I footprint assay performed on a DNA fragment that encompassed the entire intergenic region between *esrB* and ETAE_0887, the adjacent upstream gene. EvrA protected a region (5′-T[TT]{.ul}A[T]{.ul}CC[A]{.ul}A[AA]{.ul}T-3′) bearing an AT-rich palindrome structure found 198 bp upstream of the *esrB* start codon ([Figure 3](#fig3){ref-type="fig"}G); this AT-rich sequence is similar to the known binding sites for other DeoR family proteins ([@bib12]). Substitution of the AT nucleotides with GC (P~*esrB*~ Mut1) but not the replacement of CC with AA (P~*esrB*~ Mut2) abolished the capacity of EvrA to bind to this fragment ([Figure 3](#fig3){ref-type="fig"}F), demonstrating that EvrA binds to a distinct site in the *esrB* promoter. These observations are consistent with the idea that EvrA modulates *E. piscicida* virulence gene expression by directly activating EsrB transcription.

Mannose Stimulates *evrA-*Dependent Virulence Gene Activation {#sec2.5}
-------------------------------------------------------------

DeoR family proteins often modulate sugar utilization ([Figure S6](#mmc1){ref-type="supplementary-material"}) ([@bib3], [@bib12], [@bib18]), and the RNA-seq experiment revealed changes in transcript levels of several sugar transport/utilization genes (e.g., *ptsH* and *manXYZ*) in the *evrA* mutant ([Figure 3](#fig3){ref-type="fig"}D). After testing various sugars, we found that supplementation of DMEM with mannose, a C-2 epimer of glucose, selectively induced P~*esrB*~-*luxAB* reporter expression, even though bacterial growth was similar in all of the fermentable carbohydrates screened ([Figures 4](#fig4){ref-type="fig"}A and [S7](#mmc1){ref-type="supplementary-material"}A). Activation of *esrB* promoter activity during growth in mannose required *evrA* ([Figures 4](#fig4){ref-type="fig"}A and [S7](#mmc1){ref-type="supplementary-material"}B), suggesting that mannose promotes *evrA*-dependent induction of *esrB* transcription. Consistent with this idea, we found that growth in mannose augmented *evrA*-dependent production of T3/T6SS proteins ([Figure 4](#fig4){ref-type="fig"}B).Figure 4Mannose Promotes EvrA-Dependent Virulence Gene Expression(A) Chromosomal P~*esrB*~-*luxAB* reporter activity in the indicated strains grown for 12 h in DMEM medium supplemented with the 5 mg/mL of indicated sugars. Data shown are the mean ± SEM of results for triplicate assays. \*p \< 0.05; \*\*\*, p \< 0.001 based on Student\'s t test.(B) ECP profiles (upper panel) and western blot (lower panel) analysis of T3SS protein EseB expression in cell lysates (WCP) of the indicated strains in the presence of 5 mg/mL glucose (glu) or mannose (man). DnaK was used as the loading control. The numbers correspond to densitometry measurements.(C) ChIP-qPCR analysis of the relative enrichment in P~*esrB*~ DNA molecules bound to EvrA from cells grown in glucose (glu) or mannose (man). The results are normalized to the control gene *gyrB* as well as to ChIPs from Δ*evrA* + pUTt-Flag cells. \*\*\*p \< 0.001, t test. NS, not significant.(D) EMSA of the binding of EvrA to P~*esrB*~ in the presence of various mannose derivatives. Purified EvrA was mixed with mannose-6-phosphate (man-6P), mannose-1-phosphate (man-1P), GDP-man, or man and then added to 20 ng of Cy5-labeled P~*esrB*~ probe. B, bound DNA; U, unbound DNA.

Chromatin immunoprecipitation (ChIP)-qPCR analyses revealed that EvrA binding to P~*esrB*~ was greater in cells grown in mannose than in glucose ([Figures 4](#fig4){ref-type="fig"}C and [S7](#mmc1){ref-type="supplementary-material"}C), suggesting that mannose can regulate EvrA DNA-binding activity. However, EMSA analysis showed that addition of mannose to EvrA did not modify its binding to the *esrB* promoter region ([Figure S7](#mmc1){ref-type="supplementary-material"}D). We hypothesized that EvrA may be directly responsive to a mannose-derived metabolite instead of the native sugar, as bacterial import systems such as the phosphotransferase system (PTS) couple sugar import to modifications such as phosphorylation. Accordingly, we found that mannose-6-phosphate (man-6P), but not mannose-1-phosphate (man-1P) or GDP-mannose, enhanced EvrA binding to the *esrB* promoter ([Figures 4](#fig4){ref-type="fig"}D and [S8](#mmc1){ref-type="supplementary-material"}A--S8D). Electrospray ionization mass spectrometry revealed that purified EvrA forms a folding-dependent complex with man-6P, strongly suggesting that EvrA can directly bind man-6P ([Figures 5](#fig5){ref-type="fig"}A and [S9](#mmc1){ref-type="supplementary-material"}).Figure 5Mannose-6-Phosphate (man-6P) Binding to EvrA Enhances *esrB* Expression(A) Electrospray ionization mass spectrometry of native and denatured EvrA C-domain complex with man-6P.(B) Structural model of EvrA interacting with an *in silico-*docked man-6P based on homology alignment to the D-ribose-5-phosphate isomerase RpiA (PDB_ID: [1LK7](pdb:1LK7){#intref0020}) ([@bib18]). The ligand M6P and residues involved in the interaction, as well as R178 were highlighted as sticks with C atoms colored in yellow and cyan (P, orange; N, blue; O, red), respectively.(C) EMSA of binding of WT or mutant EvrA to P~*esrB*~ in the presence of man-6P. Purified EvrA or its variants mixed with man-6P and 20 ng of Cy5-labeled P~*esrB*~ probe were added to the EMSA reactions. B, bound DNA; U, unbound DNA.(D) Chromosomal P~*esrB*~-*luxAB* reporter activity in the indicated strains grown for 12 h in DMEM medium supplemented with glucose or mannose. Data shown are the mean ± SEM of results for triplicate assays. \*p \< 0.05; \*\*\*, p \< 0.001 based on Student\'s t test. NS, not significant.(E) Western blot analysis of T3SS protein EseB expression in cell lysates of the indicated strains in the presence of glucose or mannose. DnaK was used as the loading control.

EvrA shares secondary structure with *Pyrococcus horikoshii* d-ribose-5-phosphate-isomerase (RpiA) ([Figure S6](#mmc1){ref-type="supplementary-material"}F). We performed homology modeling using the known crystal structure of RpiA bound to its ligand (PDB [1LK7](pdb:1LK7){#intref0010}) ([@bib18]), to predict how EvrA binds man-6P ([Figure 5](#fig5){ref-type="fig"}B). The modeling suggests that EvrA binding to man-6P is dominated by ionic interactions between the phosphate group of the sugar and the sidechain of R221, which protrudes into the binding pocket. The main chain nitrogen atoms of S96 and T97 also likely participate in ligand coordination through hydrogen bonds. Besides R221, two additional arginines were targeted for mutagenesis: R178 from the DeoRC domain, which is predicted to be dispensable for ligand binding, and R7 from the unmodeled HTH domain, which is likely critical for EvrA promoter recognition ([Figures 5](#fig5){ref-type="fig"}B, [S6](#mmc1){ref-type="supplementary-material"}D, and S6E).

Biophysical characterization of man-6P-EvrA binding by isothermal titration calorimetry indicated that the complex forms at a micromolar *K*~d~ (22.5 μM) with a 1:1 stoichiometry, comparable with other known DeoR-ligand interactions ([Figure S8](#mmc1){ref-type="supplementary-material"}A) ([@bib18]). Alanine substitutions at R221, but not the predicted DNA-contacting R7 or the neutral R178, substantially eliminated man-6P binding to EvrA ([Figures S8](#mmc1){ref-type="supplementary-material"}E--S8G), supporting the role of the R221 in coordinating ligand binding ([Figure 5](#fig5){ref-type="fig"}B). The binding studies were corroborated with EMSA-based binding analyses. Man-6P stimulated binding of WT and R178A EvrA to P~*esrB*~ ([Figure 5](#fig5){ref-type="fig"}C) but did not modify binding of the R7A or R221A forms of the protein, presumably because of the loss of their DNA or ligand recognition capacities, respectively ([Figures 5](#fig5){ref-type="fig"}C and [S8](#mmc1){ref-type="supplementary-material"}H). The reasons why EvrA^R221A^ bound the P~*esrB*~ probe with lower apparent affinity than the WT protein ([Figure S8](#mmc1){ref-type="supplementary-material"}H) are not known, but it is possible that the WT protein may co-purify with bound man-6P. Next, we expressed the mutant EvrA proteins in *E. piscicida* ([Figure S10](#mmc1){ref-type="supplementary-material"}A) to test their function in cells. Only *E. piscicida* strains expressing EvrA or EvrA^R178A^ led to auto-aggregation ([Figure S10](#mmc1){ref-type="supplementary-material"}B) and exhibited mannose augmentation of *esrB* expression and EseB production ([Figures 5](#fig5){ref-type="fig"}D, 5E, and [S10](#mmc1){ref-type="supplementary-material"}C). Thus, EvrA\'s capacity to bind man-6P and DNA appear to be critical for the protein to promote virulence gene expression.

We speculated that EvrA might also play a role in mannose uptake because the transcriptomic data suggested that EvrA modestly represses *manX* (FC ∼ 2) ([Figure 3](#fig3){ref-type="fig"}D and [Table S13](#mmc7){ref-type="supplementary-material"}), a component of the mannose-specific PTS, which imports mannose into the cell ([@bib9]). Growth of WT *E. piscicida* in mannose augmented *evrA* expression but decreased *manX* expression, suggestive of negative feedback ([Figure S7](#mmc1){ref-type="supplementary-material"}E). Consistent with the RNA-seq data, the Δ*evrA* mutant had higher levels of *manX* transcripts than the WT grown in mannose as well as in glucose, suggesting that EvrA represses *manX* expression ([Figure S7](#mmc1){ref-type="supplementary-material"}E). Since EvrA binds to the *manX* promoter region via an AT-rich palindrome ([Figure S7](#mmc1){ref-type="supplementary-material"}F), these findings suggest that EvrA directly represses the *manXYZ* operon. Collectively, these observations are consistent with the idea that EvrA directly represses *manX* expression, potentially creating a negative feedback loop dampening mannose-induced, *evrA*-dependent induction of *esrB* expression ([Figure S4](#mmc1){ref-type="supplementary-material"}C).

Mannose Augments *E. piscicida* Virulence in an *evrA-*Dependent Manner {#sec2.6}
-----------------------------------------------------------------------

Finally, we investigated the roles of *evrA*, *manX*, and mannose in *E. piscicida* virulence in turbot. As shown previously, the Δ*esrB*, ΔT3SS, and ΔT6SS mutant strains were highly attenuated and ∼90% of fish remained alive at 14 d.p.i ([Figure 6](#fig6){ref-type="fig"}A) ([@bib35]). The Δ*evrA* and Δ*manX* mutants were also attenuated with a median survival time of over 14 and 7 days, respectively ([Figure 6](#fig6){ref-type="fig"}A). More than 50% of fish survived infection with the Δ*evrA* mutant, and although no animals survived infection with the Δ*manX* mutant, these animals survived longer than animals infected with the WT strain (p = 0.0038, [Figure 6](#fig6){ref-type="fig"}A). These observations are congruent with the diminished *in vivo* fitness of both the *evrA* (FC = 0.13) and *manX* (FC = 0.24) transposon mutants observed in the TIS screen ([Table S10](#mmc1){ref-type="supplementary-material"}) and demonstrate that *evrA* and *manX* contribute to *E. piscicida* virulence.Figure 6Mannose Promotes *E. piscicida* pathogenicity in an EvrA-Dependent Manner(A) Survival curves of turbot challenged with the indicated strains. Phosphate-buffered saline (PBS, pH 7.4) supplemented with 5 mg/mL glucose and mannose was used as a control. The bacterial strains were suspended in PBS with or without 5 mg/mL glucose or mannose and injected into each turbot at a dose of 2.0 × 10^4^ CFU/fish (*n* = 30 fish/group). Kaplan-Meier survival analysis with a log rank test is shown. \*\*, p \< 0.001; NS, not significant, p \> 0.05.(B) *In vivo* P~*eseB*~*-luc* plasmid reporter activity and associated liver CFU burden at 8 d.p.i. from fish inoculated with the indicated strains. \*\*\*, p \< 0.001 based on ANOVA analysis of the relative fluorescence units (RFU) and the bacterial burden (*n* = 3).(C) Survival curves of turbot challenged with the indicated strains. PBS supplemented with 5 mg/mL mannose was used as a control; otherwise these data were acquired and analyzed identically to that in (A).(D) Mannose (blue) and man-6P/man-1P (red) levels in extracts from turbot intestines or livers before (filled) or after (open) infection with WT *E. piscicida* (left) and in WT *E. piscicida* grown in DMEM supplemented with glucose or mannose (right). Mean ± SE from five fish or three bacterial samples are shown; there was no detectable mannose in the intestine of turbot or in *E. piscicida*, which is indicated by \*, below detection limit. p Values are calculated based on unpaired two-tailed Student\'s t test.(E) Schematic of *E. piscicida* mannose responsive virulence gene regulatory circuit.

Co-inoculation of the WT strain with mannose (5 mg/mL), but not glucose (5 mg/mL), accelerated the mortality of the fish (p = 0.0045, [Figure 6](#fig6){ref-type="fig"}A), consistent with the prior observation in carp that elevated tissue mannose, and man-6P levels are correlated with lethal *E. tarda* infection [@bib39]. In contrast, co-inoculation of the Δ*evrA* or Δ*manX* strains in mannose or glucose did not alter the kinetics of fish survival (p \> 0.05, [Figure 6](#fig6){ref-type="fig"}A). Mannose supplementation also led to increased expression of *eseB in vivo* and greater *E. piscicida* proliferation ([Figure 6](#fig6){ref-type="fig"}B). In this assay, strains expressing the *evrA* mutants that were incapable of mannose-stimulated *esrB* expression in culture (EvrA^R221A^ and EvrA^R7A^) phenocopied the *evrA* deletion mutant ([Figure 6](#fig6){ref-type="fig"}B). Similarly, strains expressing these non-functional EvrA mutants were as attenuated *in vivo* as the strain lacking *evrA* ([Figure 6](#fig6){ref-type="fig"}C); in contrast, the strain expressing the mannose-response *evrA* mutant (EvrA^R178A^) killed fish with similar kinetics as the WT.

The observation that EvrA^R221A^ phenocopied the Δ*evrA* strain, even in the absence of mannose supplementation, suggests that during infection, the EvrA ligand is present and detected by EvrA. Mannose and mannose phosphates (man-6P and man-1P) were found at micromolar levels in the intestines and livers of uninfected turbot ([Figure 6](#fig6){ref-type="fig"}D). Consistent with their micromolar presence *in vivo*, man-6P/man-1P accumulated to micromolar levels in *E. piscicida* grown in mannose-supplemented cultures, suggesting that the ligand of EvrA (but not its precursor) can naturally accumulate in the intracellular bacterial space ([Figure 6](#fig6){ref-type="fig"}D). Furthermore, levels of mannose and man-6P/man-1P were greater in livers from infected fish than those in naive fish, suggesting that *E. piscicida* growth *in vivo* may stimulate host production of this sugar. Moreover, *esrB* expression could be efficiently activated by mannose concentrations detected *in vivo* (20--200 μM, [Figure S11](#mmc1){ref-type="supplementary-material"}). These findings are consistent with the idea that mannose stimulation of EvrA-dependent induction of virulence gene expression can promote *E. piscicida* pathogenicity during infection and that exposure to host mannose can prime *E. piscicida*\'s virulence.

Discussion {#sec3}
==========

*E. piscicida* and closely related *Edwardsiella* species are important fish pathogens that inflict great damage on the aquaculture industry globally. These facultative intracellular organisms are particularly compelling for pathogenesis studies because their virulence depends on both T3SS and T6SS ([@bib31], [@bib34], [@bib37]). The defined *E*. *piscicida* transposon mutant library ([Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc2){ref-type="supplementary-material"}) and the resulting genome-scale datasets representing the genetic requirements for the pathogen\'s growth in DMEM, J774A.1 cells, and fish ([Tables S8--S10](#mmc1){ref-type="supplementary-material"}, [Figure S4](#mmc1){ref-type="supplementary-material"}C) presented here should provide a valuable resource for future analyses of this pathogen\'s virulence and functional genomics. There was a remarkable congruence in the observations derived from the three TIS screens and in studies using 28 deletions mutants ([Figure 2](#fig2){ref-type="fig"}), including in the magnitudes of the calculated fitness defects for both insertion and deletion mutants, suggesting that the findings from the screens are robust. Besides confirming the importance of the *E. piscicida* T3/T6SS for turbot growth, our findings delineated many metabolic pathways that the organism depends on to proliferate during infection ([Figure S4](#mmc1){ref-type="supplementary-material"}C) and revealed a new positive regulator of virulence, EvrA.

The genes found to facilitate *E. piscicida* fitness in the DMEM, J774A.1, and turbot screens were largely distinct, reflecting the manifold differences in these conditions. The genes enabling robust growth in J774A.1 cells and in DMEM did not overlap, and only 28/67 genes facilitating growth in these murine macrophage-like cells were scored as important for fitness in turbot ([Figures 1](#fig1){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}C). Furthermore, there were nearly 4x as many genes required for fitness in turbot than in J774A.1 cells, illustrating the more diverse demands imposed by an intact host versus the intracellular milieu. The 230 genes facilitating growth in turbot but not J774A.1 cells enable both extracellular and intracellular growth *in vivo*; furthermore, the pathogen may proliferate within more than one cell type *in vivo* ([@bib17]). Entry into and growth within J774A.1 cells and turbot macrophages required *E. piscicida\'s* T3SS but not its T6SS, even though both secretion systems are required *in vivo*. Thus, the organism may rely on its T6SS primarily for extracellular growth in fish where it may facilitate competition with tissue-resident microbiota to support pathogen colonization ([@bib4], [@bib11], [@bib36]).

The utility of the defined mutant library is underscored by the secondary screen that led to the rapid identification of EvrA, a new regulator of *E. piscicida* virulence. EvrA acts upstream of the master virulence regulator EsrB to influence the expression of both the T3SS and T6SS, while also likely coordinating a negative feedback loop with its ligand, man-6P, to fine-tune its activity ([Figure 6](#fig6){ref-type="fig"}E). We found that EvrA is specifically activated by man-6P, the cytosolic form of mannose imported by the PTS, and that mannose is found in the tissues of *E. piscicida*\'s host. Our discovery of the EvrA-man-6P regulatory axis suggests that specific carbohydrates may be co-opted as signaling intermediaries between host and microbe in addition to their known roles as substrates for metabolism ([@bib5], [@bib24]). For example, availability of fucose in the mammalian intestine acts as a spatial cue for virulence regulation in enterohemorrhagic *Escherichia coli* ([@bib25]). Additionally, the conservation of EvrA in other virulent microbes, including the close relative *Salmonella enterica* ([Figure S6](#mmc1){ref-type="supplementary-material"}), suggests that directly coupling detection of host sugars to virulence regulation may be a common theme in bacterial pathogenesis.

We posit that mannose detection by *E. piscicida* can be used both to regulate its virulence and to support its metabolism, although the exact contribution of host mannose to bacterial growth *in vivo* remains to be determined. In the proposed model, EvrA serves as a "metabolic switch" that links availability of a specific nutrient to activation of the virulence program ([Figure 6](#fig6){ref-type="fig"}E). Although it is not clear whether mannose is present outside the host, upregulation of host-specific colonization factors such as the T3SS would suggest it may serve as a host niche-specific signal. Future analysis of additional transposon libraries in *E. piscicida* strains lacking EvrA will enable additional understanding of the pathogen\'s metabolic priorities and whether other sugars may play complementary roles to mannose in virulence regulation. This work deepens our understanding of how bacterial pathogens can unite sugar availability and virulence regulation and establishes a framework for future studies that employ high-throughput genetics to dissect the metabolic cross talk between pathogen and host.

Limitations of the Study {#sec3.1}
------------------------

The principal limitation of the study is that we were unable to obtain structural data that confirmed direct binding of man-6P to EvrA. Crystallization of the EvrA-man-6P complex proved extremely difficult because purified EvrA is prone to precipitation. Co-expression of protein tags, chaperones, or protein truncations may circumvent these issues and facilitate the future structural and biochemical analysis of EvrA and EvrA-man-6P complex.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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